MSP RECOVERY CLAIMS, SERIES LLC et al v. CELGENE CORPORATION et al
Case Number:
2:21-cv-20451
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 04, 2022
Celgene Can't Delay Cancer Drug Antitrust Case, Court Told
Drug payors pressed a New Jersey federal judge Thursday not to let Celgene Corp. and parent Bristol-Myers Squibb Co. "delay justice and perpetuate the illegal conduct" preventing generic competition for two blockbuster cancer drugs, arguing that the drugmakers cannot use separate, "significantly different" litigation to justify a pause.
-
February 22, 2022
Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs
Two nonprofits have been added to a sweeping antitrust lawsuit accusing Celgene Corp. and parent Bristol-Myers Squibb Co. of stifling generic competition for two blockbuster cancer drugs and driving up prices for secondary payers of health care claims.